Clinical investigation
Aspirin therapy: Optimized platelet inhibition with different loading and maintenance doses

https://doi.org/10.1016/0002-8703(95)90353-4Get rights and content

Abstract

Inhibition of cyclooxygenase by aspirin has been shown to be beneficial in clinical situations such as acute myocardial infarction or unstable angina. The precise effect of various doses of aspirin on acute and long-term inhibition of platelet aggregation and thromboxane synthesis remains unclear. In this study we evaluated the effect of oral aspirin (0, 40, 100, 300, or 500 mg) as the initial loading dose in combination with different maintenance doses of aspirin (0, 40, or 100 mg/day) for 14 days on platelet function in healthy men. Bleeding time 2 or 24 hours after the first aspirin administration was significantly increased for 300 and 500 mg aspirin (p < 0.01). Two hours after the first administration of 100, 300, and 500 mg aspirin, a significant inhibition of collagen-induced platelet aggregation (ED50 collagen: from 3 ± 1 to 17 ± 2, 24 ± 3, 22 ± 3 μg/ml, respectively) was seen. At the same time serum thromboxane B2 synthesis was inhibited by more than 99% with 300 and 500 mg aspirin. At the end of the 14-day observation period, bleeding time was significantly prolonged for the different combinations of aspirin doses compared with initial values (p < 0.01). Collagen-induced platelet aggregation and serum thromboxane B2 synthesis were significantly inhibited for all aspirin combinations tested at 14 days (p < 0.05). The 4040 mg aspirin combination was less effective, because it reached its maximal effect very late at day 7 of the observation period compared with the other combinations. The results of our study indicate that a loading dose of 300 mg aspirin in combination with 40 mg as a maintenance dose resulted in sufficient inhibition of platelet aggregation and of thromboxane synthesis during the 14-day observation period.

References (31)

  • EMG Hoogendijk et al.

    Aspirin and platelets

    Lancet

    (1980)
  • J O'Grady et al.

    Aspirin: a paradoxical effect on bleeding time

    Lancet

    (1978)
  • DL Lewis et al.

    Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina: results of a Veteran Administration cooperative study

    N Engl J Med

    (1983)
  • Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease

    Lancet

    (1990)
  • R De Caterina et al.

    Equal antiplatelet effects of aspirin 50 or 324 mg/day in patients after acute myocardial infarction

    Thromb Haemost

    (1985)
  • GJ Roth et al.

    Acetylation of prostaglandin synthetase by aspirin

  • JB Smith et al.

    Aspirin selectively inhibits prostaglandin production in human platelets

    Nature

    (1971)
  • PJ Prichard et al.

    Human gastric mucosal bleeding induced by low dose aspirin, but not warfarin

    Br Med J

    (1989)
  • CJ Hawkey et al.

    Prophylaxis of aspirin induced gastric mucosal bleeding with ranitidine

    Alimentary Pharmacol Ther

    (1988)
  • GA Fitzgerald et al.

    Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man

    J Clin Invest

    (1983)
  • P Patrignani et al.

    Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects

    J Clin Invest

    (1982)
  • S Moncada et al.

    An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation

    Nature

    (1976)
  • J Tateson et al.

    Effect of Prostacyclin (PGX) on cyclic AMP concentrations in human platelets

    Prostaglandins

    (1977)
  • C Patrono et al.

    Clinical pharmacology of platelet cyclooxygenase inhibition

    Circulation

    (1985)
  • GAR Born

    Aggregation of blood platelets by adenosine diphosphate and its reversal

    Nature

    (1962)
  • Cited by (0)

    Supported by the Deutsche Forschungsgemeinschaft, Bonn (grant DA 168/2-1).

    View full text